Merck KGaA, Nano-Terra extend alliance
EMD Chemicals Inc., the US division of Merck KGaA of Germany, said today it is extending its existing alliance with Nano-Terra Inc., a Cambridge start-up focused on nano-technology.
EMD said in a press release: "The original agreement between the companies, announced in February 2007, was to develop innovative, nanotechnology-based products and solutions based on Merck’s materials. After successfully meeting initial development milestones, this new agreement will focus on specific application development for Merck customers and moving the technical capabilities into the marketplace for commercialization. Under the new agreement, which extends the partnership through 2011, Nano-Terra will develop novel application techniques for existing Merck materials which are designed to address market opportunities where smaller feature sizes are required for certain printable electronics components."
Nano-Terra is a privately-held research and development company that has licenses to more than 50 patents on work done by company cofounder George Whitesides (left) at the Whitesides Lab at Harvard University, where he is the Woodford L. and Ann A. Flowers university professor.
To read an earlier story about Nano-Terra, please click here.
(By Chris Reidy, Globe staff. 2005 file photo of Whitesides: David Kamerman, Globe staff.)
